Antipsychotic drugs activate SREBP-regulated expression of lipid biosynthetic genes in cultured human glioma cells: a novel mechanism of action?

Several studies have reported on structural abnormalities, decreased myelination and oligodendrocyte dysfunction in post-mortem brains from schizophrenic patients. Glia-derived cholesterol is essential for both myelination and synaptogenesis in the CNS. Lipogenesis and myelin synthesis are thus interesting etiological candidate targets in schizophrenia. Using a microarray approach, we here demonstrate that the antipsychotic drugs clozapine and haloperidol upregulate several genes involved in cholesterol and fatty acid biosynthesis in cultured human glioma cells, including HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase), HMGCS1 (3-hydroxy-3-methylglutaryl-coenzyme A synthase-1), FASN (fatty acid synthase) and SCD (stearoyl-CoA desaturase). The changes in gene expression were followed by enhanced HMGCR-enzyme activity and elevated cellular levels of cholesterol and triglycerides. The upregulated genes are all known to be controlled by the sterol regulatory element-binding protein (SREBP) transcription factors. We show that clozapine and haloperidol both activate the SREBP system. The antipsychotic-induced SREBP-mediated increase in glial cell lipogenesis could represent a novel mechanism of action, and may also be relevant for the metabolic side effects of antipsychotics.

[1]  Joseph L Goldstein,et al.  SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. , 2002, The Journal of clinical investigation.

[2]  L. Akslen,et al.  Characteristics of human and rat glioma cells grown in a defined medium. , 1988, Anticancer research.

[3]  H. Nasrallah.  A review of the effect of atypical antipsychotics on weight , 2003, Psychoneuroendocrinology.

[4]  Paul J. Harrison,et al.  Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence , 2005, Molecular Psychiatry.

[5]  G. Ness.  Developmental regulation of the expression of genes encoding proteins involved in cholesterol homeostasis. , 1994, American journal of medical genetics.

[6]  D J Mikulis,et al.  Cerebral gray matter volume deficits in first episode psychosis. , 1998, Archives of general psychiatry.

[7]  C. Aston,et al.  Microarray analysis of postmortem temporal cortex from patients with schizophrenia , 2004, Journal of neuroscience research.

[8]  I. Shimomura,et al.  Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. , 1997, The Journal of clinical investigation.

[9]  H Rusinek,et al.  Volumetric measure of the frontal and temporal lobe regions in schizophrenia: relationship to negative symptoms. , 2000, Archives of general psychiatry.

[10]  R. B. Rawson.  The SREBP pathway — insights from insigs and insects , 2003, Nature Reviews Molecular Cell Biology.

[11]  T. Steck,et al.  Cholesterol homeostasis. Modulation by amphiphiles. , 1994, The Journal of biological chemistry.

[12]  M. Verheijen,et al.  Local regulation of fat metabolism in peripheral nerves. , 2003, Genes & development.

[13]  J. Lieberman,et al.  Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs , 2005, Molecular Psychiatry.

[14]  T M Hyde,et al.  Psychiatric disturbances in metachromatic leukodystrophy. Insights into the neurobiology of psychosis. , 1992, Archives of neurology.

[15]  J. Sutcliffe,et al.  Antipsychotic drug treatment alters expression of mRNAs encoding lipid metabolism-related proteins , 2003, Molecular Psychiatry.

[16]  M. Brown,et al.  Active and inactive forms of 3-hydroxy-3-methylglutaryl coenzyme A reductase in the liver of the rat. Comparison with the rate of cholesterol synthesis in different physiological states. , 1979, The Journal of biological chemistry.

[17]  L. Witters,et al.  Acetyl-CoA carboxylase and SREBP expression during peripheral nervous system myelination. , 2003, Biochimica et biophysica acta.

[18]  M. Heo,et al.  Antipsychotic-induced weight gain: a comprehensive research synthesis. , 1999, The American journal of psychiatry.

[19]  T. Steck,et al.  Regulation of endoplasmic reticulum cholesterol by plasma membrane cholesterol. , 1999, Journal of lipid research.

[20]  C. Göritz,et al.  CNS synaptogenesis promoted by glia-derived cholesterol. , 2001, Science.

[21]  J. Newcomer,et al.  Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia. , 2004, The Journal of clinical psychiatry.

[22]  Ron Kikinis,et al.  Progressive decrease of left Heschl gyrus and planum temporale gray matter volume in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. , 2003, Archives of general psychiatry.

[23]  J. Lieberman,et al.  Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. , 2001, The American journal of psychiatry.

[24]  Peter B. Jones,et al.  Oligodendrocyte dysfunction in schizophrenia and bipolar disorder , 2003, The Lancet.

[25]  J. Goldstein,et al.  Direct binding of cholesterol to the purified membrane region of SCAP: mechanism for a sterol-sensing domain. , 2004, Molecular cell.

[26]  P. Liddle,et al.  Brain imaging in schizophrenia , 2007 .

[27]  K. Blennow,et al.  Altered thalamic membrane phospholipids in schizophrenia: a postmortem study , 2004, Biological Psychiatry.

[28]  R. Campenot,et al.  Glial Lipoproteins Stimulate Axon Growth of Central Nervous System Neurons in Compartmented Cultures* , 2004, Journal of Biological Chemistry.

[29]  Paul J. Harrison.  Neuropathology of schizophrenia , 2005 .

[30]  R. Murray,et al.  Meta-analysis of regional brain volumes in schizophrenia. , 2000, The American journal of psychiatry.

[31]  K. Melkersson,et al.  Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications. , 2004, Drugs.

[32]  T. Sigmundsson,et al.  Structural abnormalities in frontal, temporal, and limbic regions and interconnecting white matter tracts in schizophrenic patients with prominent negative symptoms. , 2001, The American journal of psychiatry.

[33]  P. Finelli.  Metachromatic leukodystrophy manifesting as a schizophrenic disorder: Computed tomographic correlation , 1985, Annals of neurology.

[34]  J. Goldstein,et al.  Cholesterol-induced conformational change in SCAP enhanced by Insig proteins and mimicked by cationic amphiphiles , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[35]  A. Koudinov,et al.  Essential role for cholesterol in synaptic plasticity and neuronal degeneration , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  H. Shimano.  Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. , 2001, Progress in lipid research.

[37]  J. Dietschy,et al.  Thematic review series: Brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal Published, JLR Papers in Press, May 16, 2004. DOI 10.1194/jlr.R400004-JLR200 , 2004, Journal of Lipid Research.

[38]  Ethan M. Goldberg,et al.  Smaller anterior hippocampal formation volume in antipsychotic-naive patients with first-episode schizophrenia. , 2003, The American journal of psychiatry.

[39]  W H Wong,et al.  Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Michael D. Nelson,et al.  Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging : A meta-analytic study , 1998 .

[41]  Philip D. Harvey,et al.  White matter changes in schizophrenia: evidence for myelin-related dysfunction. , 2003, Archives of general psychiatry.